Pfizer buying King Pharmaceuticals

Pfizer recently announced it's purchase of King Pharmaceuticals for #3.6 billion. Big pharma continues to buy small Pharma firms looking to acquire new products to their pipelines.

King's main products include, pain drugs, including painkillers designed to be resistant to abuse, and EpiPen, a pre-filled injection to treat allergic reactions. Pfizer has stated that they will cut $200 million in costs. News Observer has the full story.

Share this article with your social network, just click below to share now!

Share |